Drug application
KINLYTIC (UROKINASE)
Drugs@FDA BLA 021846 · MICROBIX BIOSYSTEMS
Key facts
| Drug name | KINLYTIC |
|---|---|
| Active ingredients | UROKINASE |
| Application type | BLA |
| Application number | 021846 |
| Company | MICROBIX BIOSYSTEMS |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 250,000 IU/VIAL |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Jan 16, 1978 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: